Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 211

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Altered calcium homeostasis in autism-spectrum disorders: evidence from biochemical and genetic studies of the mitochondrial aspartate/glutamate carrier AGC1

Open access
Palmieri, L, Papaleo, V, Porcelli, V, Scarcia, P, Gaita, L, Sacco, R, Hager, J, Rousseau, F, Curatolo, P, Manzi, B, Militerni, R, Bravaccio, C, Trillo, S, Schneider, C, Melmed, R, Elia, M, Lenti, C, Saccani, M, Pascucci, T, Puglisi-Allegra, S, Reichelt, K-L, Persico, A M·2010·Molecular Psychiatry

Abstract

Autism is a severe developmental disorder, whose pathogenetic underpinnings are still largely unknown. Temporocortical gray matter from six matched patient–control pairs was used to perform post-mortem biochemical and genetic studies of the mitochondrial aspartate/glutamate carrier (AGC), which participates in the aspartate/malate reduced nicotinamide adenine dinucleotide shuttle and is physiologically activated by calcium (Ca2+). AGC transport rates were significantly higher in tissue homogenates from all six patients, including those with no history of seizures and with normal electroencephalograms prior to death. This increase was consistently blunted by the Ca2+ chelator ethylene glycol tetraacetic acid; neocortical Ca2+ levels were significantly higher in all six patients; no difference in AGC transport rates was found in isolated mitochondria from patients and controls following removal of the Ca2+-containing postmitochondrial supernatant. Expression of AGC1, the predominant AGC isoform in brain, and cytochrome c oxidase activity were both increased in autistic patients, indicating an activation of mitochondrial metabolism. Furthermore, oxidized mitochondrial proteins were markedly increased in four of the six patients. Variants of the AGC1-encoding SLC25A12 gene were neither correlated with AGC activation nor associated with autism-spectrum disorders in 309 simplex and 17 multiplex families, whereas some unaffected siblings may carry a protective gene variant. Therefore, excessive Ca2+ levels are responsible for boosting AGC activity, mitochondrial metabolism and, to a more variable degree, oxidative stress in autistic brains. AGC and altered Ca2+ homeostasis play a key interactive role in the cascade of signaling events leading to autism: their modulation could provide new preventive and therapeutic strategies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/mp.2008.63

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Research works printed but not linked: 50

  1. Rutter M . Incidence of autism spectrum disorders: changes over time and their meaning. Acta Paediatr 2005; 94: 2–15. · DOI · Paper page
  2. Persico AM, Bourgeron T . Searching for ways out of the autism maze: genetic, epigenetic and environmental clues. Trends Neurosci 2006; 29: 349–358. · DOI · Paper page
  3. Miller MT, Stromland K, Ventura L, Johansson M, Bandim JM, Gillberg C . Autism associated with conditions characterized by developmental errors in early embryogenesis: a mini review. Int J Dev Neurosci 2005; 23: 201–219. · DOI
  4. Teitelbaum O, Benton T, Shah PK, Prince A, Kelly JL, Teitelbaum P . Eshkol-Wachman movement notation in diagnosis: the early detection of Asperger's syndrome. Proc Natl Acad Sci USA 2004; 101: 11909–11914. · DOI · Paper page
  5. Sacco R, Militerni R, Frolli A, Bravaccio C, Gritti A, Elia M et al. Clinical, morphological, and biochemical correlates of head circumference in autism. Biol Psychiatry 2007; 62: 1038–1047. · DOI
  6. Wakefield AJ, Ashwood P, Limb K, Anthony A . The significance of ileo-colonic lymphoid nodular hyperplasia in children with autistic spectrum disorder. Eur J Gastroenterol Hepatol 2005; 17: 827–836. · DOI
  7. Jyonouchi H, Geng L, Ruby A, Zimmerman-Bier B . Dysregulated innate immune responses in young children with autism spectrum disorders: their relationship to gastrointestinal symptoms and dietary intervention. Neuropsychobiology 2005; 51: 77–85. · DOI · Paper page
  8. Reichelt WH, Knivsberg AM, Nodland M, Stensrud M, Reichelt KL . Urinary peptide levels and patterns in autistic children from seven countries, and the effect of dietary intervention after 4 years. Dev Brain Dysfunct 1997; 10: 44–55.
  9. Chugani DC, Sundram BS, Behen M, Lee ML, Moore GJ . Evidence of altered energy metabolism in autistic children. Prog Neuropsychopharmacol Biol Psychiatry 1999; 23: 635–641. · DOI · Paper page
  10. Correia C, Coutinho AM, Diogo L, Grazina M, Marques C, Miguel T et al. Brief report: high frequency of biochemical markers for mitochondrial dysfunction in autism: no association with the mitochondrial aspartate/glutamate carrier SLC25A12 gene. J Autism Dev Disord 2006; 36: 1137–1140. · DOI
  11. Ramoz N, Reichert JG, Smith CJ, Silverman JM, Bespalova IN, Davis KL et al. Linkage and association of the mitochondrial aspartate/glutamate carrier SLC25A12 gene with autism. Am J Psychiatry 2004; 161: 662–669. · DOI · Paper page
  12. Segurado R, Conroy J, Meally E, Fitzgerald M, Gill M, Gallagher L . Confirmation of association between autism and the mitochondrial aspartate/glutamate carrier SLC25A12 gene on chromosome 2q31. Am J Psychiatry 2005; 162: 2182–2184. · DOI
  13. Palmieri F . The mitochondrial transporter family (SLC25): physiological and pathological implications. Pflugers Arch 2004; 447: 689–709. · DOI · Paper page
  14. Palmieri L, Pardo B, Lasorsa FM, del Arco A, Kobayashi K, Iijima M et al. Citrin and aralar1 are Ca2+-stimulated aspartate/glutamate transporters in mitochondria. EMBO J 2001; 20: 5060–5069. · DOI · Paper page
  15. Satrustegui J, Pardo B, del Arco A . Mitochondrial transporters as novel targets for intracellular calcium signaling. Physiol Rev 2007; 87: 29–67. · DOI · Paper page
  16. Ramos M, del Arco A, Pardo B, Martinez-Serrano A, Martinez-Morales JR, Kobayashi K et al. Developmental changes in the Ca2+-regulated mitochondrial aspartate–glutamate carrier aralar1 in brain and prominent expression in the spinal cord. Brain Res Dev Brain Res 2003; 143: 33–46. · DOI
  17. del Arco A, Morcillo J, Martinez-Morales JR, Galian C, Martos V, Bovolenta P et al. Expression of the aspartate/glutamate mitochondrial carriers aralar1 and citrin during development and in adult rat tissues. Eur J Biochem 2002; 269: 3313–3320. · DOI
  18. Tufty RM, Kretsinger RH . Troponin and parvalbumin calcium binding regions predicted in myosin light chain and T4 lysozyme. Science 1975; 187: 167–169. · DOI · Paper page
  19. Lasorsa FM, Pinton P, Palmieri L, Fiermonte G, Rizzuto R, Palmieri F . Recombinant expression of the Ca2+-sensitive aspartate/glutamate carrier increases mitochondrial ATP production in agonist-stimulated CHO cells. J Biol Chem 2003; 278: 38686–38692. · DOI
  20. Campbell DB, D'Oronzio R, Garbett K, Ebert PJ, Mirnics K, Levitt P et al. Disruption of cerebral cortex MET signaling in autism spectrum disorder. Ann Neurol 2007; 62: 243–250. · DOI · Paper page
  21. Lintas C, Sacco R, Garbett K, Mirnics K, Militerni R, Bravaccio C et al. Involvement of the PRKCB1 gene in autistic disorder: significant genetic association and reduced neocortical gene expression. Mol Psychiatry 2008; [e-pub ahead of print]. · DOI
  22. Darley-Usmar VM, Rickwood D, Wilson MT (eds). Mitochondria, A Practical Approach. IRL Press: Washington, DC, 1987.
  23. Palmieri F, Indiveri C, Bisaccia F, Iacobazzi V . Mitochondrial metabolite carrier proteins: purification, reconstitution, and transport studies. Methods Enzymol 1995; 260: 349–369. · DOI · Paper page
  24. Grynkiewicz G, Poenie M, Tsien RY . A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260: 3440–3450. · DOI · Paper page
  25. Conciatori M, Stodgell CJ, Hyman SL, O'Bara M, Militerni R, Bravaccio C et al. Morphogenetic effect of the HOXA1 A218G polymorphism on head circumference in patients with autism. Biol Psychiatry 2004; 55: 413–419. · DOI
  26. Lord C, Rutter M, DiLavore PC, Risi S . ADOS, Autism Diagnostic Observation Schedule. Western Psychological Services: Los Angeles, 2002 (Italian version ed. by Tancredi R, Saccani M, Persico AM, Parrini B, Igliozzi R and Faggioli R. Organizzazioni Speciali: Florence, 2005).
  27. Rutter M, Le Couter A, Lord C . ADI-R, Autism Diagnostic Interview—Revised. Western Psychological Services: Los Angeles, 2003 (Italian version ed. by Faggioli R, Saccani M, Persico AM, Tancredi R, Parrini B and Igliozzi R. Organizzazioni Speciali: Florence, 2005).
  28. Sacco R, Papaleo V, Hager J, Rousseau F, Moessner R, Militerni R et al. Case–control and family-based association studies of candidate genes in autistic disorder and its endophenotypes: TPH2 and GLO1. BMC Med Genet 2007; 8: 11. · DOI
  29. Barrett JC, Fry B, Maller J, Daly MJ . Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263–265. · DOI · Paper page
  30. Horvath S, Xu X, Lake SL, Silverman EK, Weiss ST, Laird NM . Family-based tests for associating haplotypes with general phenotype data: application to asthma genetics. Genet Epidemiol 2004; 26: 61–69. · DOI · Paper page
  31. Spielman RS, Ewens WJ . The TDT and other family-based tests for linkage disequilibrium and association. Am J Hum Genet 1996; 59: 983–989.
  32. Dudbridge F . Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 2003; 25: 115–121. · DOI · Paper page
  33. Pritchard JK, Stephens M, Donnelly P . Inference of population structure using multilocus genotype data. Genetics 2000; 155: 945–959. · DOI · Paper page
  34. Krey JF, Dolmetsch RE . Molecular mechanisms of autism: a possible role for Ca2+ signaling. Curr Opin Neurobiol 2007; 17: 112–119. · DOI · Paper page
  35. Hope CI, Sharp DM, Hemara-Wahanui A, Sissingh JI, Lundon P, Mitchell EA et al. Clinical manifestations of a unique X-linked retinal disorder in a large New Zealand family with a novel mutation in CACNA1F, the gene responsible for CSNB2. Clin Experiment Ophthalmol 2005; 33: 129–136. · DOI
  36. Laumonnier F, Roger S, Guerin P, Molinari F, M'rad R, Cahard D et al. Association of a functional deficit of the BKCa channel, a synaptic regulator of neuronal excitability, with autism and mental retardation. Am J Psychiatry 2006; 163: 1622–1629. · DOI · Paper page
  37. Rizzuto R, Bernardi P, Pozzan T . Mitochondria as all-round players of the calcium game. J Physiol 2000; 529: 37–47. · DOI · Paper page
  38. Lohiya GS, Tan-Figueroa L, Iannucci A . Identification of low bone mass in a developmental center: finger bone mineral density measurement in 562 residents. J Am Med Dir Assoc 2004; 5: 371–376. · DOI
  39. Jaffe JS, Timell AM, Gulanski BI . Prevalence of low bone density in women with developmental disabilities. J Clin Densitom 2001; 4: 25–29. · DOI
  40. Blasi F, Bacchelli E, Carone S, Toma C, Monaco AP, Bailey AJ et al. SLC25A12 and CMYA3 gene variants are not associated with autism in the IMGSAC multiplex family sample. Eur J Hum Genet 2006; 14: 123–126. · DOI
  41. Rabionet R, McCauley JL, Jaworski JM, Ashley-Koch AE, Martin ER, Sutcliffe JS et al. Lack of association between autism and SLC25A12. Am J Psychiatry 2006; 163: 929–931. · DOI
  42. Jacquemont ML, Sanlaville D, Redon R, Raoul O, Cormier-Daire V, Lyonnet S et al. Array-based comparative genomic hybridisation identifies high frequency of cryptic chromosomal rearrangements in patients with syndromic autism spectrum disorders. J Med Genet 2006; 43: 843–849. · DOI · Paper page
  43. Autism Genome Project Consortium, Szatmari P, Paterson AD, Zwaigenbaum L, Roberts W, Brian J, Liu XQ et al. Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet 2007; 39: 319–328. · DOI · Paper page
  44. Bernard S, Enayati A, Roger H, Binstock T, Redwood L . The role of mercury in the pathogenesis of autism. Mol Psychiatry 2002; 7: S42–S43. · DOI
  45. Nelson KB, Bauman ML . Thimerosal and autism? Pediatrics 2003; 111: 674–679. · DOI
  46. Elferink JG . Thimerosal: a versatile sulfhydryl reagent, calcium mobilizer, and cell function-modulating agent. Gen Pharmacol 1999; 33: 1–6. · DOI
  47. Burbacher TM, Shen DD, Liberato N, Grant KS, Cernichiari E, Clarkson T . Comparison of blood and brain mercury levels in infant monkeys exposed to methylmercury or vaccines containing thimerosal. Environ Health Perspect 2005; 113: 1015–1021. · DOI · Paper page
  48. Hornig M, Chian D, Lipkin WI . Neurotoxic effects of postnatal thimerosal are mouse strain dependent. Mol Psychiatry 2004; 9: 833–845. · DOI · Paper page
  49. Brown MJ, Willis T, Omalu B, Leiker R . Deaths resulting from hypocalcemia after administration of edetate disodium: 2003–2005. Pediatrics 2006; 118: e534–e536. · DOI
  50. Sinha Y, Silove N, Williams K . Chelation therapy and autism. BMJ 333: 756. · doi:10.1136/bmj.333.7571.756

Cited by

Metadata

Authors
Palmieri, L., Papaleo, V, Porcelli, V, Scarcia, P., Gaita, L., Sacco, R., Hager, J., Rousseau, F., Curatolo, P., Manzi, B., Militerni, R., Bravaccio, C., Trillo, S., Schneider, C., Melmed, R., Elia, M., Lenti, C., Saccani, M., Pascucci, T., Puglisi-Allegra, S., Reichelt, K.-L., & Persico, A. M.
Venue
Molecular Psychiatry
Published
2008-07-08
Volume
15
Issue
1
Pages
38-52
ISSN
  • 1359-4184 (ISSN-L)
  • 1476-5578
OpenAlex
W2045192866
Cited by
211
References
14
FWCI
6.33
Type
journal article
Language
en
Open access
green
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.